期刊文献+

清金化痰汤辅助治疗肺癌合并肺部感染的效果及对KPS评分的影响 被引量:39

Clinical efficacy and change of KPS score of Qingjinhuatan decoction in the treatment of lung cancer combined with pulmonary infection
下载PDF
导出
摘要 目的分析清金化痰汤联合头孢哌酮钠舒巴坦钠治疗肺癌合并肺部感染的效果及对患者体力状态的影响。方法选取86例肺癌合并肺部感染患者。根据治疗方法不同分为对照组(头孢哌酮钠舒巴坦钠+常规对症治疗)43例和观察组(头孢哌酮钠舒巴坦钠+常规对症治疗+清金化痰汤)43例。比较两组患者的发热、咳嗽、肺部啰音的改善时间及治疗前后的痰培养阳性率、血清炎性细胞因子水平[肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、C反应蛋白(CRP)、降钙素原(PCT)、白细胞介素-2(IL-2)、白细胞介素-10(IL-10)、白细胞介素-13(IL-13)]、卡氏功能状态(KPS)评分。结果观察组患者发热、咳嗽、肺部啰音的改善时间分别为(7.86±2.02)、(9.87±2.14)、(11.74±1.98)天,均明显短于对照组的(9.96±1.75)、(11.75±2.36)、(13.02±2.52)天(P<0.01);两组患者治疗前的血清炎性细胞因子水平及治疗前后的痰培养阳性率、KPS评分比较,差异均无统计学意义(P﹥0.05);治疗后,观察组患者的IL-2水平明显高于对照组,TNF-α、IL-1β、CRP、PCT、IL-10、IL-13水平均明显低于对照组(P<0.01)。结论与头孢哌酮钠舒巴坦钠联合常规对症治疗比较,加用清金化痰汤治疗肺癌合并肺部感染,可调节血清炎性细胞因子水平,缩短肺部啰音、咳嗽的改善时间。 Objective To analyze the clinical effect of Qingjinhuatan decoction combined with cefoperazone sodium and sulbactam sodium in the treatment of lung cancer with pulmonary infection,and the effect on the patients’performance status.Method A total of 86 patients of lung cancer with pulmonary infection were included in the study and assigned into control group(cefoperazone sodium and sulbactam sodium+routine symptomatic treatment,n=43)and study group(cefoperazone sodium and sulbactam sodium+routine symptomatic treatment+Qingjinhuatan decoction,n=43),respectively.The time to recovery of fever,cough,lung rales,as well as the positive rate of sputum culture,serum level of inflammatory cytokines[tumor necrosis factor-α(TNF-α),interleukin-1β(IL-1β),C-reactive protein(CRP),procalcitonin(PCT),IL-2,IL-10,IL-13]and Karnofsky performance status(KPS)scores before and after treatment were compared between the two groups.Result The time to recovery of fever,cough and lung rales were(7.86±2.02),(9.87±2.14)and(11.74±1.98)d,respectively in study group,and were significantly shorter compared to those in control group at(9.96±1.75),(11.75±2.36)and(13.02±2.52)d,respectively(P<0.01).There was no statistically significant difference in regard to the level of serum inflammatory factors and positive rate of sputum culture and KPS score before and after treatment(P>0.05).After treatment,the IL-2 level in study group was significantly higher than that in the control group and the TNF-α,IL-1β,CRP,PCT,IL-10,and IL-13 levels were evidently lower(P<0.01).Conclusion Compared with the routine symptomatic therapy+cefoperazone sodium and sulbactam sodium,the addition of Qingjinhuatan decoction could mediate the level of serum inflammatory factors,shorten the time needed for recovery from lung rale and cough when treating lung cancer combined with pulmonary infection.
作者 巫小云 张丽 王甜甜 WU Xiaoyun;ZHANG Li;WANG Tiantian(Department of Traditional Chinese Medicine,Affiliated Dongfeng Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Oncology,Affiliated Dongfeng Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China)
出处 《癌症进展》 2019年第10期1208-1211,共4页 Oncology Progress
关键词 清金化痰汤 头孢哌酮钠舒巴坦钠 肺癌 肺部感染 Qingjinhuatan decoction cefoperazone sodium and sulbactam sodium lung cancer pulmonary infection
  • 相关文献

参考文献8

二级参考文献78

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2施毅.美国胸科学会医院获得性肺炎最新诊治指南给我们的启示[J].中国呼吸与危重监护杂志,2005,4(4):248-249. 被引量:198
  • 3刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:788
  • 4陈平,王勇,文小玲,宋精玲,林萍,杨承纲,刘美玉,李维波.中晚期乳腺浸润性导管癌癌线粒体及溶酶体的体视学分析[J].中国医学物理学杂志,2007,24(3):200-201. 被引量:1
  • 5Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 6de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 7Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 8Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 9Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 10Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.

共引文献3097

同被引文献456

引证文献39

二级引证文献164

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部